← Leaderboards
Steven David Freedman
Beth Israel Deaconess Medical Center
$3,089,605
Attributed
$4,024,018
Total exposure
20
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $709.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,024,018 · 20
By mechanism
R01$3,097,036 · 2
R03$336,005 · 1
S07$300,000 · 1
M01$282,892 · 15
P41$8,085 · 1
Top collaborators
- Dipak Panigrahy2 shared
- Charles Nicholas Serhan2 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Susan L Greenspan$27,746,173
- Michael B Atkins$4,622,469
- Dong-Er Zhang$30,254,830
- Raghu Kalluri$29,360,132
- David McDermott$9,360,637
Others in their field
Top investigators on “Chloride Channels”
- John F Engelhardt · University Of Iowa$15,217,384
- Garry R Cutting · Johns Hopkins University$12,808,832
- Michael Jay Holtzman · Washington University$11,705,628
- Robert C Griggs · University Of Rochester$11,593,605
- H. Criss Hartzell · Emory University$10,885,275
- Paul A Welling · University Of Maryland Baltimore$9,692,893
Research focus
Chloride ChannelsClinical ResearchHuman SubjectGene MutationResearch PersonnelCystic FibrosisPrimary Sclerosing CholangitisResourcesSourceInstitutionPancreatitisFundingGrantPathologic ProcessComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthGenetic ScreeningLaboratory MouseDisease /Disorder EtiologyDisease /Disorder ModelProtein Structure FunctionInflammationNucleic Acid SequenceOmega 3 Fatty Acid
Grant awards (38)
Control of cancer cachexia via stimulation of resolution of inflammation$691,696
R01 · FY2025 · CA
Control of cancer cachexia via stimulation of resolution of inflammation$709,923
R01 · FY2024 · CA
TMS FOR PAIN IN CHRONIC PANCREATITIS$5,839
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: DHA FOR THE TREATMENT OF PRIMARY SLCEROSING CHOLANGITIS$1,196
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: VX-770 IN CYSTIC FIBROSIS SUBJECTS WITH GENOTYPE 551D$211
M01 · FY2008 · RR · contact PI
EFFECT OF LINOLEIC ACID ON INFLAMMATORY MARKERS IN CYSTIC FIBROSIS$70
M01 · FY2008 · RR · contact PI
TMS FOR PAIN IN CHRONIC PANCREATITIS$59,891
M01 · FY2007 · RR · contact PI
DHA FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS$34,054
M01 · FY2007 · RR · contact PI
ACINAR-DUCT CELL COUPLING IN PANCREATIC FUNCTION$282,729
R01 · FY2006 · DK · contact PI
TMS treatment for pain in chronic pancreatitis$166,005
R03 · FY2006 · DK · contact PI
TMS FOR PAIN IN CHRONIC PANCREATITIS$134,228
M01 · FY2006 · RR · contact PI
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE IN PRIMARY SCLEROSING CHOLANGITIS$9,049
M01 · FY2006 · RR · contact PI
CYSTIC FIBROSIS GENE DEFECTS DATA SHARING PROJECT$8,085
P41 · FY2006 · RR · contact PI
DHA FOR THE TREATMENT OF PSC$2,514
M01 · FY2006 · RR · contact PI
ACINAR-DUCT CELL COUPLING IN PANCREATIC FUNCTION$289,532
R01 · FY2005 · DK
TMS treatment for pain in chronic pancreatitis$170,000
R03 · FY2005 · DK
RTMS IN CHRONIC PANCREATITIS PAIN$17,293
M01 · FY2005 · RR
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE IN PRIMARY SCLEROSING CHOLANGITIS$6,371
M01 · FY2005 · RR
CURCUMINOIRDS IN CYSTIC FIBROSIS: NTPD MEASUREMENT$1,820
M01 · FY2005 · RR
ACINAR-DUCT CELL COUPLING IN PANCREATIC FUNCTION$289,532
R01 · FY2004 · DK
Relation of mutation in cystic fibrosis gene to defects in fatty acid metabolism$5,696
M01 · FY2004 · RR
Curcuminoids/NTPD$3,107
M01 · FY2004 · RR
rTMS in Chronic Pancreatitis Pain$1,553
M01 · FY2004 · RR
ACINAR-DUCT CELL COUPLING IN PANCREATIC FUNCTION$289,532
R01 · FY2003 · DK
Improvement of AE monitoring$150,000
S07 · FY2003 · RR
ACINAR-DUCT CELL COUPLING IN PANCREATIC FUNCTION$329,375
R01 · FY2002 · DK
Improvement of AE monitoring$150,000
S07 · FY2002 · RR
CFTR FUNCTION/ GENE MUTATION IN PRIMARY SCLEROSING CHOLA$0
M01 · FY2002 · RR
DETERMINATION OF CFTR GENE MUTATIONS IN RECURRENT &CHRONIC PANCREATI$0
M01 · FY2002 · RR
DETERMINATION OF CFTR GENE MUTATIONS IN RECURRENT &CHRONIC PANCREATI$0
M01 · FY2001 · RR
CFTR FUNCTION/ GENE MUTATION IN PRIMARY SCLEROSING CHOLA$0
M01 · FY2001 · RR
ACINAR/DUCT CELL COUPLING IN PANCREATIC FUNCTION$214,717
R01 · FY2000 · DK
DETERMINATION OF CFTR GENE MUTATIONS IN RECURRENT &CHRONIC PANCREATI$0
M01 · FY2000 · RR
CFTR FUNCTION/ GENE MUTATION IN PRIMARY SCLEROSING CHOLA$0
M01 · FY2000 · RR
CFTR FUNCTION/ GENE MUTATION IN PRIMARY SCLEROSING CHOLA$0
M01 · FY2000 · RR
CFTR FUNCTION/ GENE MUTATION IN PRIMARY SCLEROSING CHOLA$0
M01 · FY2000 · RR
DETERMINATION OF CFTR GENE MUTATIONS IN RECURRENT &CHRONIC PANCREATI$0
M01 · FY2000 · RR
DETERMINATION OF CFTR GENE MUTATIONS IN RECURRENT &CHRONIC PANCREATI$0
M01 · FY2000 · RR